Amarin Corp Plc (AMRN)

[heysfguy]

Why I expect good news related to scripts and financing matters:

1) Partnerships. Now with 1A injunction in place, and AMRN working with FDA on a meaningful settlement (in terms of promoting V off-label, etc.), I expect one of the big benefits would be a significant improvement in chances of additional partnership deals. This improves both financing and script revenues.

2) Off-label promotions. Some here believe FDA is always in a retaliatory / adversarial relationship with AMRN and "don't care" to change their stance. But I believe court decisions have a way of making regulatory agencies care, and care very much. FDA is 0-fr-2 on significant regulatory issues here. If you think 1A and NCE decisions are minor, I encourage you to re-think your perspective on what kinds of leverage it gives AMRN in promoting V.

All it probably takes for the PPS to experience a significant rise at this point would be a meaningful labeling settlement or another partnership deal, etc. Or any of a dozen other "minor" developments.

Even something mundane, such as the Jeffries conference, may provide significant illumination at this point.

My advice: Buy while you can. Especially if you need to cover a short position.